Characterization of gene expression changes in human neural stem cells and endothelial cells modeling a neurovascular microenvironment.


Journal

Brain research bulletin
ISSN: 1873-2747
Titre abrégé: Brain Res Bull
Pays: United States
ID NLM: 7605818

Informations de publication

Date de publication:
05 2020
Historique:
received: 26 12 2019
revised: 12 02 2020
accepted: 19 02 2020
pubmed: 25 2 2020
medline: 1 9 2021
entrez: 25 2 2020
Statut: ppublish

Résumé

Angiogenesis-mediated neovascularization correlates with recovery after intracerebral implantation of neural stem cells (NSCs) in stroke. To elucidate NSCs' mechanism of action, it is essential to understand how these interact with the brain's vasculature after implantation. Using an all-human endothelial cell (EC, D3 cell line) and NSC (STROC05 and CTXOE03) co-culture model, fluorescently activated cell sorting (FACS) was used to isolate each cell type for a comparison of gene expression between monocultures of undifferentiated proliferating and differentiated non-proliferating cells. Gene expression for angiogenic factors (vascular endothelial growth factor, platelet derived growth factor, angiopoietin), as well as cell survival (brain derived neurotrophic factor, fibroblast growth factor) and migration (stromal cell-derived factor-1a) were measured and contrasted with the corresponding receptors on each cell type. The cellular source of extracellular matrix defining the basement membrane (vitronectin, fibronectin, laminin, collagen I and IV) and neuropil (hyaluronic acid, aggrecan, neurocan, thrombospondin, nidogen and brain associated link protein-1) was evaluated for NSCs and ECs. Co-culturing dramatically changed the expression profiles of each cell type in comparison to undifferentiated, but also differentiated cells. These results indicate that monocultures provide a poor model to investigate the cellular signaling involved in a tissue repair response. Co-cultures of NSCs and ECs forming vasculature-like structures (VLS) provide a more complex model to investigate NSC-induced neovascularization. These in vitro studies are essential to tease out individual cell signaling in NSCs and ECs to develop a mechanistic understanding of the efficacy of NSCs as a therapeutic for stroke.

Identifiants

pubmed: 32092433
pii: S0361-9230(19)31050-0
doi: 10.1016/j.brainresbull.2020.02.008
pmc: PMC7103513
mid: NIHMS1571377
pii:
doi:

Substances chimiques

Brain-Derived Neurotrophic Factor 0
Fibroblast Growth Factors 62031-54-3

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

9-19

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/D014808/1
Pays : United Kingdom
Organisme : NINDS NIH HHS
ID : R01 NS082226
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Références

Front Biosci (Schol Ed). 2011 Jun 01;3:1165-79
pubmed: 21622263
Pharm Res. 2014 Dec;31(12):3229-50
pubmed: 25098812
Anat Embryol (Berl). 1993 Nov;188(5):419-33
pubmed: 7508695
Int J Dev Neurosci. 2014 Nov;38:74-8
pubmed: 25124373
Stem Cells. 2011 Feb;29(2):274-85
pubmed: 21732485
Cell Transplant. 2002;11(3):283-95
pubmed: 12075994
J Cardiovasc Transl Res. 2012 Oct;5(5):618-30
pubmed: 22644724
Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):548-53
pubmed: 9435229
Stem Cells Int. 2016;2016:5380560
pubmed: 27656216
Brain Pathol. 2009 Oct;19(4):573-85
pubmed: 18662234
PLoS One. 2014 Sep 04;9(9):e106346
pubmed: 25187991
Sci Rep. 2017 Dec 11;7(1):17349
pubmed: 29229920
Cell Rep. 2015 Feb 24;10(7):1158-72
pubmed: 25704818
Neurochem Int. 2019 Jun;126:69-73
pubmed: 30851365
FASEB J. 2005 Nov;19(13):1872-4
pubmed: 16141364
Cell Transplant. 2013;22(9):1541-52
pubmed: 23067568
Stem Cells Int. 2019 Mar 18;2019:4978917
pubmed: 31011333
J Cereb Blood Flow Metab. 2018 Oct;38(10):1667-1681
pubmed: 30058456
J Neurosci. 2010 Mar 31;30(13):4573-84
pubmed: 20357108
Stem Cells. 2012 Apr;30(4):785-96
pubmed: 22213183
Open Biol. 2019 Jan 31;9(1):180216
pubmed: 30958121
J Neuropathol Exp Neurol. 2002 Sep;61(9):778-88
pubmed: 12230324
Exp Neurol. 2006 May;199(1):143-55
pubmed: 16464451
Proc Natl Acad Sci U S A. 2004 Dec 28;101(52):18117-22
pubmed: 15608062
Front Neurosci. 2017 Oct 24;11:590
pubmed: 29123467
Am J Pathol. 1987 Jul;128(1):78-90
pubmed: 2440308
Sci Rep. 2016 Jul 04;6:29029
pubmed: 27374240
Mol Cell Biol. 2001 Sep;21(17):5970-8
pubmed: 11486035
Cell Mol Life Sci. 2019 Aug;76(16):3229-3248
pubmed: 31197404
Int J Mol Sci. 2018 May 04;19(5):
pubmed: 29734653
Biochim Biophys Acta. 2014 Aug;1840(8):2506-19
pubmed: 24418517
Int J Mol Sci. 2019 Mar 30;20(7):
pubmed: 30935023
J Histochem Cytochem. 2018 Sep;66(9):643-662
pubmed: 29683384
J Neurosci. 2020 Feb 12;40(7):1453-1482
pubmed: 31896673
Angiogenesis. 2011 May;14(2):173-85
pubmed: 21253820
J Cereb Blood Flow Metab. 2008 Apr;28(4):764-71
pubmed: 17971789
Front Cell Neurosci. 2018 Aug 20;12:268
pubmed: 30177874
Neurorehabil Neural Repair. 2009 Nov;23(9):895-909
pubmed: 19633272
Int J Mol Sci. 2014 Apr 16;15(4):6453-74
pubmed: 24743889
J Physiol Pharmacol. 2009 Oct;60 Suppl 4:95-104
pubmed: 20083857
J Cereb Blood Flow Metab. 2017 Oct;37(10):3300-3317
pubmed: 28753105
Brain Res Dev Brain Res. 2001 Sep 23;130(1):123-32
pubmed: 11557101
Stem Cells Dev. 2017 Jun 15;26(12):857-874
pubmed: 28398169
Sci Rep. 2019 Nov 29;9(1):17874
pubmed: 31784595
J Neurosci Res. 2006 Dec;84(8):1656-68
pubmed: 17061253
Stroke. 2019 Nov;50(11):3299-3306
pubmed: 31658004
J Cereb Blood Flow Metab. 2008 Oct;28(10):1722-32
pubmed: 18594557
J Neurosci Res. 2006 Apr;83(5):845-56
pubmed: 16477652
Stem Cells Dev. 2011 Nov;20(11):1873-87
pubmed: 21345011
Biochem Biophys Res Commun. 2010 Mar 26;394(1):146-52
pubmed: 20188072
Stroke. 2018 May;49(5):1099-1106
pubmed: 29669872
Stem Cell Reports. 2018 Aug 14;11(2):552-564
pubmed: 30057262
Stem Cells Dev. 2017 Jul 1;26(13):933-947
pubmed: 28446071
In Vitro Cell Dev Biol Anim. 1997 Oct;33(9):684-91
pubmed: 9358284
Stem Cells. 2008 Sep;26(9):2444-54
pubmed: 18635871
Development. 2012 Apr;139(8):1371-80
pubmed: 22434866
Brain Behav. 2019 Mar;9(3):e01214
pubmed: 30747485
Cell Commun Signal. 2019 Mar 20;17(1):26
pubmed: 30894190
Sci Rep. 2015 Dec 07;5:17948
pubmed: 26639755
PLoS One. 2013 Oct 11;8(10):e76265
pubmed: 24146847

Auteurs

Chung-Hsing Chou (CH)

Department of Neurology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC; Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan, ROC; McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, USA.

Michel Modo (M)

McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, USA; Department of Radiology, University of Pittsburgh, Pittsburgh, USA; Department of Bioengineering, University of Pittsburgh, Pittsburgh, USA. Electronic address: mmm154@pitt.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH